scholarly journals Cases of anaphylaxis after the Comirnaty© vaccine and promotion of allergy epidemic are unfavourable for the National Vaccination Programme – recommendations of the epidemiology experts-team and of the national consultant in allerglogy are unrealistic

2021 ◽  
Vol 8 (1) ◽  
pp. 9-18
Author(s):  
Michał Kurek
2002 ◽  
Vol 6 (5) ◽  
Author(s):  
H Houweling

The Gezondheidsraad (Health Council) in the Netherlands was asked to advise the minister of health on the revision and possible expansion of the national vaccination programme, and consequently published a recommendation on universal vaccination against infections with group C meningococci and pneumococci recently.


2001 ◽  
Vol 5 (51) ◽  
Author(s):  
G Gonçalves ◽  
M. A. Santos ◽  
S Afonso ◽  
R Jorge ◽  
C D Pinheiro ◽  
...  

The recommendations for adult immunisation in Portugal’s Programa Nacional de Vacinação (PNV, national vaccination programme) (1) include the following.


2002 ◽  
Vol 6 (12) ◽  
Author(s):  
Ø Løvoll ◽  
S Sandbu

The Gezondheidsraad (Health Council) in the Netherlands was asked to advise the minister of health on the revision and possible expansion of the national vaccination programme, and consequently published a recommendation on universal vaccination against infections with group C meningococci and pneumococci recently (1).


1998 ◽  
Vol 3 (12) ◽  
pp. 119-21 ◽  
Author(s):  
G Gonçalves ◽  
A de Araújo ◽  
M. L. Monteiro Cardoso

Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinação: PNV) for both sexes at 15 months. In November 1990,


2021 ◽  
Author(s):  
Susan Mary Sherman ◽  
Julius Sim ◽  
Megan Cutts ◽  
Hannah Dasch ◽  
Richard Amlot ◽  
...  

Aim: To investigate factors associated with intention to have the COVID-19 vaccination following initiation of the UK national vaccination programme. Methods: 1,500 adults completed an online cross-sectional survey (13th to 15th January 2021). Linear regression analyses were used to investigate associations between intention to be vaccinated for COVID-19 and sociodemographic factors, previous influenza vaccination, attitudes and beliefs about COVID-19, attitudes and beliefs about COVID-19 vaccination and vaccination in general. Participants main reasons for likely vaccination uptake/decline were also solicited. Results: 73.5% of participants (95% CI 71.2%, 75.7%) reported being likely to be vaccinated against COVID-19, 17.3% were unsure (95% CI 15.4%, 19.3%), and 9.3% (95% CI 7.9%, 10.8%) reported being unlikely to be vaccinated. The full regression model explained 69.8% of the variance in intention. Intention was associated with having been/intending to be vaccinated for influenza last winter/this winter, and with stronger beliefs about social acceptability of a COVID-19 vaccine; the need for vaccination; adequacy of information about the vaccine; and weaker beliefs that the vaccine is unsafe. Beliefs that only those at serious risk of illness should be vaccinated and that the vaccines are just a means for manufacturers to make money were negatively associated with vaccination intention. Conclusions: Most participants reported being likely to get the COVID-19 vaccination. COVID-19 vaccination attitudes and beliefs are a crucial factor underpinning vaccine intention. Continued engagement with the public with a focus on the importance and safety of vaccination is recommended.


Sign in / Sign up

Export Citation Format

Share Document